IEI associated with AAN-I-IFN
| IEI | Affected gene (inheritance) | Primary cellular defect | Prevalence AAN-I-IFN | AAN against other cytokines |
|---|---|---|---|---|
| APS-1 | AIRE (AR) | AIRE+ mTEC | 97% | IL-17A, IL-17F, IL-22, IFN-λ1 |
| RAG deficiency | RAG1 or RAG2 (AR) | T-lymphocytes | 50% | TNF-α, IL-1Ra, IL-6, IL-12p70, IL-17A, IL-17B, IL-17D, CCL1, IFN-γ, IFN-λ 1, IFN-λ2 |
| IPEX | FOXP3 (X-linked recessive) | Treg | 83% | IL-17A |
| NF-κB2 deficiencya | NFKB2 (AD) | AIRE+ mTEC | 59% | |
| NIK deficiency | NIK (AR) | AIRE+ mTEC | 100% | |
| RELB deficiency | RELB (AR) | AIRE+ mTEC | 87% | |
| IP | NEMO (X-linked dominant) | ? | 36% |
| IEI | Affected gene (inheritance) | Primary cellular defect | Prevalence AAN-I-IFN | AAN against other cytokines |
|---|---|---|---|---|
| APS-1 | AIRE+ mTEC | 97% | IL-17A, IL-17F, IL-22, IFN-λ1 | |
| RAG deficiency | T-lymphocytes | 50% | TNF-α, IL-1Ra, IL-6, IL-12p70, IL-17A, IL-17B, IL-17D, CCL1, IFN-γ, IFN-λ 1, IFN-λ2 | |
| IPEX | Treg | 83% | IL-17A | |
| NF-κB2 deficiency | AIRE+ mTEC | 59% | ||
| NIK deficiency | AIRE+ mTEC | 100% | ||
| RELB deficiency | AIRE+ mTEC | 87% | ||
| IP | ? | 36% |
p52LOF/IκBδGOF deficiency. AR autosomal recessive. AD autosomal dominant.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.